Indian Army Drug Procurement Rivastigmine Melatonin Letrozole Flupentixol Ambrisentan Tender 2026

Tender Overview

The Indian Army, under the Department of Military Affairs, is issuing a pharmaceutical supply procurement for five medicines including Rivastigmine 3 mg, Melatonin 3 mg, Letrozole 2.5 mg, Flupentixol 3 mg, and Ambrisentan 5 mg. The BOQ lists 5 items with quantity details not disclosed in the data. Bidders must meet regulatory requirements and provide a compliant drug license, batch test certificates, and price compliance details. The contract allows a 25% quantity variation during and after award, with delivery timelines linked to the last delivery order. This procurement emphasizes government price controls and quality assurance through NABL/NABL-compliant testing. Unique compliance clauses favor manufacturers with CDSCO/DCGI licenses and OEM authorization where applicable. This tender signals a structured government batch purchase, requiring stringent documentation and adherence to price ceilings.

Technical Specifications & Requirements

• Medicines named: Rivastigmine 3 mg Tab, Melatonin 3 mg Tab, Letrozole 2.5 mg Tab, Flupentixol 3 mg Tab, Ambrisentan 5 mg Tab.
• Compliance documents: Drug License (CDSCO/DCGI), DPCO ceiling price adherence, Batch test certificate from Govt-authorized lab/NABL.
• Pricing: Include MRP, GST%, and MFG company in a Compliance Sheet per bid, with DO/AoM details.
• OEM Authorization: Where applicable, provide Manufacturer Authorization.
• Delivery: 25% quantity variation permitted; extended delivery time formula; minimum 30 days if extended.
• ATC documentation: Noted as required by Buyer terms.
• Quality control: Non-provision leads to rejection; NABL/NABL batch testing mandatory.

Terms, Conditions & Eligibility

• EMD: Not explicitly stated in data; bidders must adhere to standard government tender practices.
• Quantity variation: Up to 25% more or less during and after award at contracted rates.
• Drug compliance: CDSCO/DCGI license, DPCO ceiling price, and batch test certificate required.
• Manufacturer authorization: Required when submitting via Authorized Distributors.
• Documentation: Compliance Sheet, OEM authorization, drug license, batch test certificates, and notarized undertakings.
• Penalties/withdrawal: Non-submission of batch certificates results in rejection and potential debarment from procurement.
• Delivery performance: Timelines tied to last delivery order; extended time calculated by (Increased quantity ÷ Original quantity) × Original delivery period, min 30 days.